ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 116 filers reported holding ACCELERON PHARMA INC in Q2 2015. The put-call ratio across all filers is 1.90 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $5,224,000 | +241.2% | 140,000 | +133.3% | 1.44% | +57.4% |
| Q4 2016 | $1,531,000 | -39.6% | 60,000 | -14.3% | 0.92% | +102.4% |
| Q3 2016 | $2,534,000 | +49.1% | 70,000 | +40.0% | 0.45% | -34.6% |
| Q2 2016 | $1,699,000 | -14.1% | 50,000 | -33.3% | 0.69% | -4.7% |
| Q1 2016 | $1,979,000 | -72.9% | 75,000 | -50.0% | 0.72% | -69.9% |
| Q4 2015 | $7,314,000 | +167.0% | 150,000 | +36.4% | 2.41% | +123.5% |
| Q3 2015 | $2,739,000 | -42.3% | 110,000 | -26.7% | 1.08% | -28.1% |
| Q2 2015 | $4,746,000 | -28.7% | 150,000 | -14.3% | 1.50% | -46.6% |
| Q1 2015 | $6,661,000 | -28.8% | 175,000 | -27.1% | 2.80% | -38.0% |
| Q4 2014 | $9,350,000 | +1136.8% | 240,000 | +860.0% | 4.52% | +1018.6% |
| Q3 2014 | $756,000 | -79.8% | 25,000 | -77.3% | 0.40% | -76.8% |
| Q2 2014 | $3,737,000 | – | 110,000 | – | 1.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |